Earnings call transcript: Almirall sees 13% sales rise in Q2 2025
PositiveFinancial Markets

Almirall has reported a remarkable 13% increase in sales for the second quarter of 2025, showcasing the company's strong performance and growth potential. This positive trend not only reflects the effectiveness of their strategies but also boosts investor confidence, making it a significant development in the pharmaceutical sector.
— Curated by the World Pulse Now AI Editorial System